Subcutaneous Ig Maintenance Therapy for Myasthenia Gravis

NCT01828294 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped Study stopped by sponsor due to difficulty enrolling at site

Conditions

Myasthenia Gravis

Interventions

DRUG: Subcutaneous immunoglobulins

Sponsor

St. Louis University

Collaborators

[object Object]